The use of SGLT2 inhibitors in people with diabetes-related foot disease: A Delphi-based consensus study. Highton P, Abdala R, Evley R, Balasubramanian V, et al. Diabetes Obes Metab 2025 Jun 11. doi: 10.1111/dom.16498.

Read + Share

Amedeo Smart

Independent Medical Education

Highton P, Abdala R, Evley R, Balasubramanian V, et al. The use of SGLT2 inhibitors in people with diabetes-related foot disease: A Delphi-based consensus study. Diabetes Obes Metab 2025 Jun 11. doi: 10.1111/dom.16498.
PMID: 40495570